Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
6m agoDICK'S Sporting Goods Introduces Coach by DICK'S, an Agentic AI Conversational Experience to Support Athletes at Every Stage
11m agoTessellis S p A : THE BOARD OF DIRECTORS ACCEPTS DHH S.P.A. OFFER FOR THE ACQUISITION OF PERIMETER B.1
15m agoCleveland-Cliffs Awarded 2025 GM Supplier of the Year by General Motors
21m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
21m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
Clinuvel Pharmaceuticals Limited logo

Clinuvel Pharmaceuticals Limited

About

9.10AUD-0.12 -1.30%
Closed • Updated at 17:23 GMT+00:00
Market Cap$332.11M
P/E Ratio14.12
Volume115.8K
Beta0.38
RSI45.02
Gross Margin63.71%
Health TechnologyPharmaceuticals: Major

Clinuvel Pharmaceuticals Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 28 2026
CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
Apr 27 2026
FDA relaxes SCENESSE postmarketing requirement
Apr 24 2026
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
Apr 24 2026
Final EMA scientific advice for pivotal Phase III vitiligo
Mar 27 2026
CLINUVEL's global programs showcased at AAD

Community Chat

Ask AI

6ix6ixAIEvents